Therapeutic Areas: Endocrinology

Choose Therapeutic Area
Oncology
Cardiology
Ophthalmology
Neurology
Endocrinology
Gastroenterology
Dermatology
Urology
Infectious diseases incl. Covid-19
Psychiatry
Rare diseases
Cromos Pharma has significant experience and expertise in conducting clinical trials in endocrinology

We have a deep understanding of the regulatory landscape, scientific knowledge, and practical experience to ensure the trials are conducted to the highest standards. Our dedicated team of professionals with specialized knowledge in endocrinology includes medical doctors, clinical research coordinators, project managers, and data managers.

Cromos Pharma’s multicountry presence ensures access to a diverse patient population, which is particularly important for endocrinology trials, where patient populations can be challenging to identify and recruit.

Being a mid-sized CRO, we are flexible and able to adapt to the needs of clinical trials of any size and phase. This includes being able to rapidly respond to changes in the regulatory landscape and being receptive to the needs of the study team.

When it comes to conducting clinical trials in endocrinology, Cromos Pharma has the expertise, experience, and infrastructure necessary to ensure that we adhere to the highest standards, while being flexible enough to adapt to the specific needs of the sponsor.

Our endocrinologic experience includes:
    • Growth Hormone Deficiency
    • Hyperthyroidism
    • Hypothyroidism
    • Obesity
    • Osteoporosis
    • Type 1 Diabetes Mellitus
    • Type 2 Diabetes Mellitus
    • Women’s Health
Cromos Pharma Endocrinology experience in the last five years
9,000
Patients
20
Studies
900
Clinical Sites
our Success story
Global Phase III trial in Type 2 Diabetes Mellitus
Click to openclose
Why Cromos Pharma
  • We are the only CRO to offer “No Patients, No Payment” risk sharing program, where the sponsor pays only if we deliver on our milestones.
  • We have the scientific and clinical expertise to support your clinical studies, from early to late phase, from single- to multi-country execution strategies.
  • By leveraging our international expertise, we deliver unparalleled results through diligent feasibility analysis, rapid startup, and accelerated recruitment, while utilizing proactive risk management strategies and maintaining the highest data quality.
  • Our team has vast expertise in organizing scientific advisory board meetings of key opinion leaders, clinicians, and industry stakeholders.

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM

more therapeutics